Natalizumab for induction of remission in Crohn's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Natalizumab for Induction of Remission in Crohn's Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438028/0/Treatments_for_the_prevention_of_Sudden_Unexpected_Death_in_Epilepsy__SUDEP_:_Cochrane_systematic_review. Accessed 20 April 2024.
Natalizumab for induction of remission in Crohn's disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438028/0/Treatments_for_the_prevention_of_Sudden_Unexpected_Death_in_Epilepsy__SUDEP_:_Cochrane_systematic_review. Accessed April 20, 2024.
Natalizumab for induction of remission in Crohn's disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438028/0/Treatments_for_the_prevention_of_Sudden_Unexpected_Death_in_Epilepsy__SUDEP_:_Cochrane_systematic_review
Natalizumab for Induction of Remission in Crohn's Disease [Internet]. In: Cochrane Abstracts. [cited 2024 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438028/0/Treatments_for_the_prevention_of_Sudden_Unexpected_Death_in_Epilepsy__SUDEP_:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Natalizumab for induction of remission in Crohn's disease
ID - 438028
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438028/0/Treatments_for_the_prevention_of_Sudden_Unexpected_Death_in_Epilepsy__SUDEP_:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -